Carter HB - Search Results

1

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report.

Johnson MH, Carter HB. Johnson MH, et al. Among authors: carter hb. Urol Case Rep. 2015 Jul 15;3(5):175-7. doi: 10.1016/j.eucr.2015.06.012. eCollection 2015 Sep. Urol Case Rep. 2015. PMID: 26793543 Free PMC article.

2

Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial.

Patel HD, Faisal FA, Trock BJ, Joice GA, Schwen ZR, Pierorazio PM, Johnson MH, Bivalacqua TJ, Han M, Gorin MA, Carter HB, Partin AW, Pavlovich CP, Allaf ME. Patel HD, et al. Among authors: carter hb. Eur Urol. 2020 Sep;78(3):360-368. doi: 10.1016/j.eururo.2020.05.001. Epub 2020 May 19. Eur Urol. 2020. PMID: 32444264 Clinical Trial.

3

Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.

Loeb S, Schaeffer EM, Chan DW, Carter HB, Walsh PC, Sokoll LJ. Loeb S, et al. Among authors: carter hb. Urology. 2009 May;73(5):947-9. doi: 10.1016/j.urology.2008.12.055. Urology. 2009. PMID: 19394489 No abstract available.

4

Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.

Loeb S, Carter HB, Schaeffer EM, Kettermann A, Ferrucci L, Metter EJ. Loeb S, et al. Among authors: carter hb. Urology. 2011 Jan;77(1):143-7. doi: 10.1016/j.urology.2010.04.068. Urology. 2011. PMID: 21195835 Free PMC article.

5

Prostate cancer in patients with the bladder exstrophy-epispadias complex: insights and outcomes.

Berkowitz J, Carter HB, Gearhart JP. Berkowitz J, et al. Among authors: carter hb. Urology. 2008 Jun;71(6):1064-6. doi: 10.1016/j.urology.2007.12.069. Epub 2008 Mar 4. Urology. 2008. PMID: 18308374 Review.

6

Prostate-specific antigen in men born with bladder exstrophy.

Silver RI, Partin AW, Epstein JI, Chan DW, Carter HB, Jeffs RD, Gearhart JP. Silver RI, et al. Among authors: carter hb. Urology. 1997 Feb;49(2):253-6. doi: 10.1016/S0090-4295(96)00438-4. Urology. 1997. PMID: 9037290 Free article.

7

Editorial Comment.

Tosoian JJ, Alam R, Carter HB. Tosoian JJ, et al. Among authors: carter hb. J Urol. 2016 Dec;196(6):1658. doi: 10.1016/j.juro.2016.06.105. Epub 2016 Sep 15. J Urol. 2016. PMID: 27639611 No abstract available.

8

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.

Patel HD, Gupta M, Tosoian JJ, Carter HB, Partin AW, Epstein JI. Patel HD, et al. Among authors: carter hb. J Urol. 2018 Nov;200(5):1068-1074. doi: 10.1016/j.juro.2018.04.058. Epub 2018 Apr 17. J Urol. 2018. PMID: 29673946

9

Biopsy criteria for determining appropriateness for active surveillance in the modern era.

Kryvenko ON, Carter HB, Trock BJ, Epstein JI. Kryvenko ON, et al. Among authors: carter hb. Urology. 2014 Apr;83(4):869-74. doi: 10.1016/j.urology.2013.12.054. Urology. 2014. PMID: 24680457

10

Overdiagnosis and overtreatment of prostate cancer.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Loeb S, et al. Among authors: carter hb. Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Eur Urol. 2014. PMID: 24439788 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters